VivoSeq
Other

Fluorescence

0

Pipeline Programs

9

Active Trials

0

Companies Involved

Fluorescence is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

25/100

Pipeline Velocity

15/100

Mech. Concentration

N/A

Completion Rate

89/100

Attrition Rate

7/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

30

clinical trials

Completed16 · 53%
Recruiting4 · 13%
Not yet recruiting4 · 13%
Unknown status3 · 10%
Terminated2 · 7%
Active, not recruiting1 · 3%

Trial Activity

30 trials

ALA-induced PpIX Fluorescence During Brain Tumor Resection
Active, not recruiting··Phase 1·NCT02191488·540 enrolled
Fluorescence-Guided Imaging of Brain Tumors: A Safety Study Using SBK2-ICG
Not yet recruiting··Phase 1·NCT07438860·12 enrolled
Fluorescence Guided Resection of Brain Tumors
Completed··Phase 1·NCT00870779·105 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)